Caption Management 13F: New $6M Stake in The Chemours (CC)

Caption Management Establishes New Position in The Chemours Company

Caption Management opened a new position in The Chemours Company NYSE:CC during the period, purchasing 270,800 shares of the specialty chemicals maker. The newly initiated stake carried a reported value of approximately $5.96 million based on the filing data. Because this was a brand-new holding for the investor, it represents a fresh commitment to the basic materials sector rather than an adjustment to an existing portfolio weight. Form 13F filings are backward-looking and reflect holdings as of the reporting date, meaning they may not represent current positions today.

The Chemours Company Stock Performance

The stock trades at $22.00 per share. That price places the shares well above their 52-week low of $10.44 and below the 52-week high of $28.67. The company has a forward P/E ratio of 7.54, though it posted a negative net margin and a loss per share of $2.02 over the trailing period, meaning it lacks a meaningful trailing P/E ratio due to a lack of profitability.

Recent Earnings and Dividend Overview

The Chemours Company reported $5.80 billion in revenue with a revenue growth rate of -1.5%. The company posted a net margin of -5.24% and a return on equity of -3.19%. Looking ahead, the company is scheduled to report its next round of earnings on November 5, 2026. Shareholders also receive an annual dividend of $0.35 per share, giving the stock a dividend yield of 2.44% with a payout ratio of 55.56%.

Analysts Set New Price Targets

Wall Street firms have adjusted their views on the stock through recent rating updates. On October 14, 2026, Mizuho downgraded the stock to a Neutral rating with a $15.00 price target. Earlier in the month on October 13, 2026, Barclays initiated coverage with an Equal-Weight rating and a $16.00 price target. UBS maintained a Neutral rating with a $16.00 price target on October 5, 2026. Mizuho also maintained an Outperform rating with an 18.00 price target on September 30, 2026, while JP Morgan kept a Neutral rating and lowered its target to $15.00 on August 13, 2026. The stock currently carries a consensus recommendation key of buy with a mean price target of $18.78 across nine analyst opinions.

Inside The Chemours Company Operations

The Chemours Company operates out of Wilmington, Delaware, supplying performance chemicals across North America, the Asia Pacific, Europe, and Latin America. The business focuses on three main segments including Thermal and Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Its Thermal and Specialized Solutions unit manufactures refrigerants and thermal management products under familiar brand names like Freon and Opteon.

What to Watch Next for Caption Management

Investors tracking Caption Management will need to wait for subsequent quarterly filings to see whether the firm builds upon its initial position or adjusts its exposure. The Chemours Company will meanwhile head toward its next earnings release in November, which will provide fresh data on revenue trends and profit margins in the basic materials sector. Regulatory filings capture past portfolio choices and should be viewed as one piece of a broader market picture rather than financial advice.